These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22298987)

  • 21. [Natural history of chronic hepatitis B virus infection].
    Vildózola Gonzales H; Salinas JL
    Rev Gastroenterol Peru; 2009; 29(2):147-57. PubMed ID: 19609330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.
    Rosenthal P; Ling SC; Belle SH; Murray KF; Rodriguez-Baez N; Schwarzenberg SJ; Teckman J; Lin HS; Schwarz KB;
    Hepatology; 2019 Jun; 69(6):2326-2337. PubMed ID: 30318613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and predictors of elevated postpartum alanine aminotransferase in chronic hepatitis B mothers: a prospective study protocol.
    OuYang S; Chen Z; Peng T; Geng Y; Qiu J; Xiao Z; Pan CQ
    BMC Gastroenterol; 2023 Nov; 23(1):387. PubMed ID: 37951866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research of hepatic pathology and clinical characteristics of patients chronic infected with hepatitis B virus in immune tolerant stage].
    You SL; Xing HQ; Liu HL; Rong YH; Zhu B; Xin SJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):374-6. PubMed ID: 18322608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus.
    Zhou J; Wang FD; Wang ML; Tao YC; Wu DB; Sheng YJ; Xiao GB; Chen XB; Chen X; Chen EQ
    Front Med (Lausanne); 2021; 8():717125. PubMed ID: 34527683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV: Do I treat my immunotolerant patients?
    Vlachogiannakos J; Papatheodoridis GV
    Liver Int; 2016 Jan; 36 Suppl 1():93-9. PubMed ID: 26725904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.
    Hui CK; Leung N; Yuen ST; Zhang HY; Leung KW; Lu L; Cheung SK; Wong WM; Lau GK;
    Hepatology; 2007 Aug; 46(2):395-401. PubMed ID: 17628874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early antiviral treatment response in HBeAg-positive chronic HBV infected-patients with high viral load and normal ALT].
    Huang Y; Du BY; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):233-237. PubMed ID: 37137846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of an outpatient chronic hepatitis B virus infection cohort.
    Assis DR; Tenore Sde B; Pinho JR; Lewi DS; Ferreira PR
    Einstein (Sao Paulo); 2015; 13(2):189-95. PubMed ID: 26154539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities.
    Gish RG; Given BD; Lai CL; Locarnini SA; Lau JY; Lewis DL; Schluep T
    Antiviral Res; 2015 Sep; 121():47-58. PubMed ID: 26092643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
    Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
    Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study.
    Hamida ME; Raja SM; Seyoum Y; Elkhidir IM; Tekle F
    BMC Gastroenterol; 2021 May; 21(1):198. PubMed ID: 33933017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008-2012: A cross-sectional study.
    Chevaliez S; Roudot-Thoraval F; Brouard C; Gordien E; Zoulim F; Brichler S; Brodard V; Pioche C; Pawlotsky JM; Leroy V;
    JHEP Rep; 2022 Dec; 4(12):100593. PubMed ID: 36313185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
    Dusheiko G
    Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research progress on the characteristics of immune tolerant phase and antiviral therapy in children with chronic hepatitis B].
    Li J; Fan PY; Hong WG; Zhang M; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1259-1265. PubMed ID: 36891708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of chronic hepatitis B virus infection.
    Villeneuve JP
    J Clin Virol; 2005 Dec; 34 Suppl 1():S139-42. PubMed ID: 16461215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural History of Chronic Hepatitis B Infection Among Chinese Children and Young Adults: A Single-Center Experience.
    Mo S; Au L; Huang S; Malik P; Pan DH
    J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):150-155. PubMed ID: 33661243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus depicts a high degree of conservation during the immune-tolerant phase in familiarly transmitted chronic hepatitis B infection: deep-sequencing and phylogenetic analysis.
    Sede M; Lopez-Ledesma M; Frider B; Pozzati M; Campos RH; Flichman D; Quarleri J
    J Viral Hepat; 2014; 21(9):650-61. PubMed ID: 25244642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.